[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.37 número3
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.37 número3" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.37 número3".
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disea[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Once her ophthalmologic exam showed only central retinal vein occlusion (CRVO), the clinical discussion focused on the etiology of the underlying process: whether it was a consequence of[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Objective: The aim of this study was to compare a fractionated dose of 15 g G-CSF/kg of body weight and the conventional dose of granulocyte-colony stimulating factor in respect to the [r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número3
... regarding the clinical impact of CALR mutations in MPNs is still under construction, but some studies indicate that CALR - mutated patients have lower ages at disease onset, lower hemogl[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número3
... An 18-year-old female patient (height 147 cm and weight 40 kg) belonging to the ‘Chasa’ caste was admitted to the Depart- ment of Medicine of Veer Surendra Sai Medical College and Hospital, Burla, Odisha, India with ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número3
... The objective of this study was to characterize the hematological parame- ters, clinical features, and molecular basis of very mild forms of Hb S/  + -Thal in a newborn cohort of Minas [r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número3
... The role of inflammation in the development of anemia in patients with CKD should be highlighted. It is known that the release of cytokines such as interferon-gamma (IFN-␥), tumor necrosis factor alpha (TNF-␣), ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.37 número3
... remission, 37% had chemosensitive disease with incom- plete remission and 0% had refractory disease) and 1-year overall survival after allogeneic transplantation was ...regimens, 37% in patients condi- ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Objective: By applying receiver operating characteristic curve analysis, the objective of this study was to see whether hemoglobin levels reflect body iron stores in a group of pregnant [r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Thus, this study aimed to characterize the demographic and socioeconomic aspects of SCD patients from the state of Rio Grande do Norte (RN), a socioeconomic vulnerable area of northeaste[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número3
... Concerning to the use of hydroxyurea, a significant dif- ference was observed in the levels of arginase I in patients who used lower doses (<20 mg/kg/day) compared to those on higher [r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número3
... The proliferation rate of peripheral blood mononuclear cells (PBMCs) was assessed by labeling with carboxyfluorescein diacetate succinimidyl ester (CFSE) and subsequent culture stimulated by phytohemagglutinin. PBMCs ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número3
... 1,2 The combination of the sickle cell mutation and beta-thalassemia (  -Thal) mutation gives rise to a compound heterozygous con- dition known as Hb S/  thalassemia (Hb S/  -Thal), w[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.37 número6
... 1 The aims of these stages are numer- ous but include improving donor awareness and trust in the blood transfusion service, encouragement to adhere to the donor selection criteria, durin[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.37 número6
... Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease – a randomized, controlled, open-label, [r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número6
... positive precursor B-cell acute lymphoblastic leukemia with positive minimal residual disease (0.32%) before conditioning treatment for hematopoietic stem cell transplantation.. In green[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.37 número6
... One of its causes is low serum vitamin B12 (cobalamin) levels, caused in 20–50% of the cases by a decrease in intrinsic factor due to atrophy of the gastric mucosa and consequently loss [r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.37 número6
... Bilateral mammography and breast ultrasound showed abnormalities of the left breast: skin thickening, diffusely hyperechogenic breast parenchyma, dilated intramammary lymphatics and a hy[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.37 número6
... A subset of patients have an isolated deletion of chromosome 5q, known as 5q- syndrome, which is characterized by a distinct set of features including severe macrocytic anemia, normal or[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.37 número6
... In cases of immune HAs (DAT positive), the diagnostic pos- sibilities are limited to the presence of autoantibodies (warm, cold or mixed), alloimmunization (as in transfusion incompat- i[r] ... See full document
3
temas relacionados